A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Procedure: Surgeries
- Registration Number
- NCT03451526
- Lead Sponsor
- Tang-Du Hospital
- Brief Summary
The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer
- Detailed Description
The trial is a multi-centre real-world non-interventional observational study. The Chinese patients with N2 non-small cell lung cancer enrolled from 2014 to 2017 who received radical resections of lung cancer and adjuvant chemotherapies will be included in the study and the study data on patient demographic/tumor biological characteristics and clinical treatment will be collected to evaluate compare effectiveness of radical resection of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies after surgeries.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2929
- Patients with radical resection of lung cancer enrolled from 2014 to 2019;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Patients with age > 18 years old;
- Patients who did not receive chest surgeries before hospitalization;
- Patients with N2 lymph nodes (+) after surgeries;
- Patients who received lymphadenectomy for one group or more groups of lymph nodes;
- Patients with second primary tumors or multiple primary tumors;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Surgeries+adjuvant chemotherapies Surgeries Patients who received radical resection of lung cancer + adjuvant chemotherapies Perioperative chemotherapies Surgeries Patients who received perioperative chemotherapies
- Primary Outcome Measures
Name Time Method Overall survival 2014 - 2017 Overall survival
- Secondary Outcome Measures
Name Time Method Disease-free survival 2014 - 2017 Disease-free survival
Trial Locations
- Locations (10)
Jiangsu cancer hospital
🇨🇳Nanjing, Jiangsu, China
Huaxi Hospital Affiliated to Sichuan University
🇨🇳Chengdu, Sichuan, China
China PLA General Hospital
🇨🇳Beijing, Beijing, China
Tongji Hospital Affiliated to Huazhong Technology Hospital
🇨🇳Wuhan, Hubei, China
Shanghai Chest Hospital
🇨🇳Shanghai, Shanghai, China
Henan cancer hospital
🇨🇳Zhengzhou, Henan, China
China-Japan Friendship Hospital
🇨🇳Beijing, Beijing, China
First Hospital Affiliated to Zhejiang University
🇨🇳Hangzhou, Zhejiang, China
Tianjin Chest Hospital
🇨🇳Tianjin, Tianjin, China
Xi'an Tangdu Hospital
🇨🇳Xi'an, Shaanxi, China